Overview

Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease

Status:
Completed

Trial end date:
2013-09-01

Target enrollment:

Participant gender:

Summary

The aim of this study was to evaluate the impact in safety and efficacy of a new formulation of prolonged-released Pirfenidone in the progression of renal damage in patients with Chronic kidney Disease (CKD).

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University of Guadalajara

Collaborator:

Cell Therapy And Technology, S.a. De C.v.

Treatments:

Pirfenidone